Adherence Intervention for Metastatic Breast Cancer
Adherence Intervention in Patients With Metastatic Breast Cancer
Recruiting
N/A
Interventional Study
Breast Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 99
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 35 (estimated)
- Sponsor
- Columbia University · Other
Who this trial is looking for
This trial is looking for patients with metastatic breast cancer who have trouble sticking to their medication plan. Participants will receive support to help improve their medication adherence.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old
- I have been diagnosed with metastatic breast cancer
- I am taking endocrine therapy
- I am taking a CDK4/6 inhibitor
- I am taking at least one medication for heart health
- I have reported some issues with taking my medications
You may not be able to join if
- I cannot speak English or Spanish
- I am not able to understand what the study involves
- I cannot give my consent for any reason
- I will not be available for follow-up for 28 weeks
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To evaluate the preliminary efficacy of a multicomponent adherence intervention focused on enhancing digital equity and pharmaco-equity among nonadherent patients with metastatic breast cancer (MBC) and cardiovascular disease (CVD) risk factors on endocrine therapy (ET), CDK4/6 inhibitor (CDK 4/6i), and CVD medications. To assess the acceptability and appropriateness of this intervention in patien…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women or men age \>18 years
* Diagnosed with stage IV/metastatic breast cancer prescribed endocrine therapy and a CDK4/6i
* Prescribed at least 1 antihypertensive or statin medication for CVD prevention or treatment
* Self-report of at least some nonadherence ET/CDK4/6i or CVD…
Contacts